Vissel B - Search Results

1

Inflammation-sleep interface in brain disease: TNF, insulin, orexin.

Clark IA, Vissel B. Clark IA, et al. Among authors: vissel b. J Neuroinflammation. 2014 Mar 21;11:51. doi: 10.1186/1742-2094-11-51. J Neuroinflammation. 2014. PMID: 24655719 Free PMC article. Review.

2

Amyloid β: one of three danger-associated molecules that are secondary inducers of the proinflammatory cytokines that mediate Alzheimer's disease.

Clark IA, Vissel B. Clark IA, et al. Among authors: vissel b. Br J Pharmacol. 2015 Aug;172(15):3714-27. doi: 10.1111/bph.13181. Epub 2015 Jun 29. Br J Pharmacol. 2015. PMID: 25939581 Free PMC article. Review.

3

Therapeutic implications of how TNF links apolipoprotein E, phosphorylated tau, α-synuclein, amyloid-β and insulin resistance in neurodegenerative diseases.

Clark IA, Vissel B. Clark IA, et al. Among authors: vissel b. Br J Pharmacol. 2018 Oct;175(20):3859-3875. doi: 10.1111/bph.14471. Epub 2018 Sep 6. Br J Pharmacol. 2018. PMID: 30097997 Free PMC article. Review.

4

The meteorology of cytokine storms, and the clinical usefulness of this knowledge.

Clark IA, Vissel B. Clark IA, et al. Among authors: vissel b. Semin Immunopathol. 2017 Jul;39(5):505-516. doi: 10.1007/s00281-017-0628-y. Epub 2017 Apr 27. Semin Immunopathol. 2017. PMID: 28451786 Free PMC article. Review.

5

Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease.

Clark IA, Vissel B. Clark IA, et al. Among authors: vissel b. Biochem Pharmacol. 2013 Oct 1;86(7):862-71. doi: 10.1016/j.bcp.2013.07.030. Epub 2013 Aug 9. Biochem Pharmacol. 2013. PMID: 23939185 Review.

6

Tumor necrosis factor-induced cerebral insulin resistance in Alzheimer's disease links numerous treatment rationales.

Clark I, Atwood C, Bowen R, Paz-Filho G, Vissel B. Clark I, et al. Among authors: vissel b. Pharmacol Rev. 2012 Oct;64(4):1004-26. doi: 10.1124/pr.112.005850. Epub 2012 Sep 10. Pharmacol Rev. 2012. PMID: 22966039 Review.

7

The roles of TNF in brain dysfunction and disease.

Clark IA, Alleva LM, Vissel B. Clark IA, et al. Among authors: vissel b. Pharmacol Ther. 2010 Dec;128(3):519-48. doi: 10.1016/j.pharmthera.2010.08.007. Epub 2010 Sep 8. Pharmacol Ther. 2010. PMID: 20813131 Review.

8

TNF and leptin tell essentially the same story in Alzheimer's disease.

Clark IA, Alleva LM, Vissel B. Clark IA, et al. Among authors: vissel b. J Alzheimers Dis. 2011;26(2):201-5. doi: 10.3233/JAD-2011-110266. J Alzheimers Dis. 2011. PMID: 21593567

9

Excess cerebral TNF causing glutamate excitotoxicity rationalizes treatment of neurodegenerative diseases and neurogenic pain by anti-TNF agents.

Clark IA, Vissel B. Clark IA, et al. Among authors: vissel b. J Neuroinflammation. 2016 Sep 5;13(1):236. doi: 10.1186/s12974-016-0708-2. J Neuroinflammation. 2016. PMID: 27596607 Free PMC article. Review.

10

A Neurologist's Guide to TNF Biology and to the Principles behind the Therapeutic Removal of Excess TNF in Disease.

Clark IA, Vissel B. Clark IA, et al. Among authors: vissel b. Neural Plast. 2015;2015:358263. doi: 10.1155/2015/358263. Epub 2015 Jul 22. Neural Plast. 2015. PMID: 26221543 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results